Anthony Venida, an HHMI Hanna Gray postdoctoral fellow at Stanford Medicine, will present his cancer and neurodegeneration research in a talk titled “Quality Control in Human Diseases: Autophagy-dependent Mechanisms in Cancer and Neurodegeneration” at a Discovery Science Emerging Scholar Lecture on Tuesday, Nov. 19, at 4:00 p.m. in 208 Light Hall.
The Discovery Science Emerging Scholar Lecture Series features the most promising young scientists who are making notable discoveries as postdoctoral fellows or early career faculty.
Venida is the Propel Postdoctoral Scholar at Stanford. He is interested in understanding the mechanisms that lead to death of dopaminergic neurons, a major pathological hallmark of Parkinson’s disease. At Stanford, Venida is studying how protein and organelle quality control mechanisms in the brain become dysfunctional and lead to buildup of toxic factors that cause disease. Using CRISPR-based technology to manipulate gene function and investigate the interplay between neurons and glial cells, he hopes to identify disease-modifying therapies that can prevent neuronal cell death.
This lecture is co-sponsored by the School of Medicine Basic Sciences and the Department of Cell and Developmental Biology.